Given the increasing popularity of a hospice inpatient/residential facility (HIRF) among hospice patients and their family members, examining who uses HIRFs has been of increasing importance. Using the 2007 National Home and Hospice Care Survey (NHHCS), we found that about 14% of the hospice patients received care in an HIRF in 2007. Characteristics of patients associated with HIRF use largely match the industry norm for a general inpatient level of care and include having no caregiver or having an incapable caregiver; having imminent death; and being directly admitted to a hospice after discharge from a hospital. Given a recent stricter enforcement of reimbursement rules, however, we call for close monitoring of any change in the number of HIRF beds-particularly in rural and low-income urban areas.
Introduction
A majority of Americans express a strong preference for dying at home, 1-2 but for many, their actual experiences have been the opposite. [3] [4] Even with hospice care that facilitates home death, not all hospice patients are able to achieve home death. This is hardly surprising because home death cannot be a desirable or feasible outcome for all. Other concerns such as pain and symptom control, safety, and quality and quantity of life become more important to patients and/or family members with time. 5 In a national survey, seriously ill patients and recently bereaved family members rated dying at home as least important of 9 attributes associated with quality care at the end of life. 6 A hospice inpatient/residential facility (HIRF) is becoming an increasingly popular option among hospice patients for both residential care and inpatient care. Hospice care is typically delivered to the patient's residence, that is, private homes with family members as primary caregivers. If the patient is at a nursing home or assisted living facility, then hospice care is delivered there, assuming that the facility staff become the primary caregivers. States are also increasingly allowing home-based hospice providers to own or lease space dedicated to hospice patients only. A hospice residential facility is considered by a patient who lives there to be his or her primary ''home.'' A hospice staff member fills the role of family caregiver with the provision of residential care for 24 hours a day, 7 days a week. The State of New York was the first state that, in 1995, passed a hospice residential facility law called the Hospice Residence law (chapter 532 of the Laws of 1995), allowing a home-based hospice provider to operate a home-like living facility for the benefit of its patients lacking caregivers to complement hospice care in their own homes. The law was intended to lessen the number of hospitalizations and/or nursing home placements. A number of states now have residential hospice facility provisions, and in some states the facilities do not have to transfer their residents with inpatient care needs to hospitals or skilled nursing facilities (SNFs), as those facilities are allowed to provide acute care within their own facilities. For example, the State of New York allows hospice residences to use up to 2 beds dually for both residential and general inpatient (GIP) care.
Medicare accounts for nearly 90% of all hospice patient care days 7 and Medicaid and private plans follow Medicare reimbursement system, where a hospice provider is paid per day by 1 of the 4 levels of care. Although a Medicare-eligible patient stays in residential care, he or she pays for room and board to the hospice residential facility, while Medicare pays the hospice residential facility at the routine home care level rate ($151 for financial year [FY] 2012), the same rate that Medicare would pay if the patient were to stay in the home. On the other hand, Medicare pays the residential facility at the rate of GIP level care ($672) if the same patient switches to that level of care for pain/symptom management for a short period of time. The patient does not pay for room and board while he or she receives GIP care as room and board cost is included in the Medicare payment. A hospice residential facility can also be used for respite care for the primary caregiver for which Medicare pays $156 per day. For respite care, the patient does not pay for room and board and respite care is limited to once in each benefit period for a maximum of 5 days.
On the other hand, there is a hospice inpatient facility that provides predominantly GIP level of care. For example, a hospice leases 1 floor of a hospital building, and hospice patients often come directly from the hospital. Patients may die there or be discharged to their home or to a nursing home after being ready for discharge. Medicare usually pays at the GIP care rate.
There is another type of hospice inpatient facility, the freestanding facility, which is not part of a hospital or SNF. This type of facility is gaining popularity among patients, and hospice providers have been constructing new facilities that are often located in suburban areas that offer a home-like atmosphere with private rooms, family rooms, family kitchens, and a 24-hour visitation policy. A freestanding hospice facility typically provides both residential and inpatient care. By including both a unit of residential beds and a unit of inpatient beds, a freestanding hospice facility hopes to increase the occupancy rate and thus, its fiscal viability. Although per-patient profits are higher for GIP care, inpatient beds turn over much faster than residential beds; the average length of stay is 30 days for residential care and only 5 to 6 days for GIP care. 8 Furthermore, to be reimbursed at the general inpatient care rate, a hospice must document that the patient meets the criteria for that higher level of care. In addition, caring for acute patients is more costly than caring for residential patients. For example, federal and state regulations require a 24-hour onsite presence of a registered nurse for inpatient care. In addition to a mix of care, hospices prefer a large number of beds in their freestanding facilities to achieve economies of scale.
Until recently, inpatient hospice care was provided almost exclusively in beds in hospitals contracted with hospices. This model, often called the scattered bed model, is still the most common model of inpatient care. 9 For patients transferred to hospitals, hospices have to follow the regulations presented in the Medicare Conditions of Participation (42 CFR Part 418), 10 which mandate that service levels and visits be congruent across care sites. If the hospice decides to follow National Hospice and Palliative Care Organization (NHPCO) guidelines, 10 then it must have a minimum of 1 interdisciplinary team member contact per day (primarily visits), supplemented with volunteer visits. In spite of this requirement, the hospice must use most of its Medicare payment to reimburse the hospital for patient costs. Furthermore, transfer to a hospital may increase the likelihood that a patient will choose to quit hospice and switch to curative treatment. 9 On the other hand, in order to keep their hospice care, a patient may feel forced to transfer to a hospital that is not his or her choice for inpatient care. 9 Not all patients transferred to hospitals receive GIP care. Some patients might need hospital level of care for acute medical events such as an injury (fall), acute deterioration of a chronic condition not related to a hospice diagnosis, or development of a new condition. For such patients, Medicare pays the hospice at the rate of routine home care level, while the hospital files a claim with regular Medicare.
In this study, we do not differentiate hospice inpatient facilities and hospice residential facilities, primarily because the data we use do not as well. However, the data available seem to indicate that GIP care may be dominant in an HIRF. 7 About 520 home-based hospice providers in operation in 2009 had HIRFs. About 48% of the HIRFs provided predominantly GIP care; about 16% provided mainly residential care; and about 36% provided mixed inpatient and residential care with both residential and inpatient beds in the building. The percentage of hospice patients receiving care in an HIRF (as a place of death) is increasing, with almost 22% having utilized an HIRF in 2010. 7 Compared to hospice care provided in a hospital, an HIRF appears to offer a higher standard in terms of quality and efficiency, since having its own facility gives a hospice more overall control over the quality and cost of care. 9 Previous studies also indicate that the satisfaction level among families of HIRF residents is higher than in any other setting. 5, [11] [12] [13] Satisfaction with care provided in HIRF was high among family members of hospice decedents, with personalized care, cleanliness of the facility and the patient, and proximity to nature being counted as reasons for high satisfaction. 5 When an HIRF was offered as an option, patients with cancer and their caregivers only preferred death at home 36% of the time; 32% had an equal preference for home or an HIRF, and 29% preferred death in an HIRF. 13 Given the rising number of HIRFs and their increasing popularity, examining the characteristics of patients utilizing such facilities is of increasing importance to ensure access to HIRFs.
Few studies are conducted to answer the question of who uses HIRFs. Although hospice residential facilities with only residential beds have been in operation for quite a long time, large freestanding HIRFs providing all levels of care including routine and GIP are a relatively new phenomenon. 8, 14, 15 Consequently, there is a paucity of data in this area.
The limited research on HIRFs treats HIRFs as part of an inpatient setting but not as distinguishable sites of care. For example, Johnson et al 16 combined HIRFs and hospitals into 1 category-an inpatient setting for hospice patients-and tried to find out the factors that predicted hospice patients' death in an inpatient setting (HIRF and hospitals) away from a hospice patients' home. Their assumption was that the factors affecting death in HIRFs and hospitals are the same. However, that assumption may not be valid.
Objectives of the Study
The first objective of this study is to provide national baseline data on the extent to which HIRFs are utilized using a national representative of patients discharged from hospice. We focus on HIRF not only as a place of discharge (ie, the site transferred from ''home'' settings including nursing homes or assisted living facilities) but also as a place of admission (when they first begin to receive hospice care). The 2007 National Home and Hospice Care Survey (NHHCS) began to include HIRF as one of the options for the sites at admission (or on the first day of hospice) and at discharge (or on the last day of hospice). The NHHCS also provides rich data on individual patient characteristics, hospice services utilized, and characteristics of hospice agencies, among others. The second objective of this study is, based on this individual-level data, to identify patients' characteristics associated with HIRF use. We used all hospice patients regardless of discharge status (death or live discharge) to explore HIRF use not limited to a place of death.
Methods

Data
Using the 2007 NHHCS, 17 we examined a nationally representative sample of 2.7 million (84%) patients discharged from hospice, primarily due to death. At the first stage of sampling, more than 15 000 home health and hospice agencies were stratified as 3 agency types (home health only, hospice only, and both care) and 3 metropolitan area status. 18 A sample of 1545 agencies was randomly selected with probability proportional to the agency staff size. Among them, 1461 (95%) selected agencies were eligible, and 1036 agencies agreed to participate (unweighted, 71%; weighted, 59%). 18 At the second stage of sampling, a computer algorithm was made to randomly select up to 10 current patients per home health agency, up to 10 hospice discharges per hospice agency, or a combination of up to 10 current home health patients and hospice discharges per mixed agency. 18 Hospice patients were sampled from discharges from hospice during a 3-month period before the month of the agency interview, while home health patients were sampled from the total number of patients on the agency rolls as of midnight on the day before the agency interview.
Data were collected through in person one-on-one interviews with the hospice staff member who knew each sampled patient. Questions were answered in consultation with the patient's medical record or other records. No patients or family members were interviewed.
Definitions of Key Variables
Place before hospice care: an agency staff was first asked, ''Immediately before the patient began receiving hospice care from this agency, was he or she an inpatient in a hospital, nursing home, or some other kind of health care facility?'' If the answer was positive, the interviewees selected one of the following options:
1. hospital/emergency room; 2. nursing home/skilled nursing facility/subacute facility; 3. rehabilitation facility; 4. assisted living; 5. 91. other (specify).
We examined the specified types of option 91, which were variants of adult foster care or home health. Home health and adult foster care are not generally considered health care facilities. For the purposes of our analysis, categories 2, 3, and 4 were combined, and category 91 and unknown responses were coded as staying in the home.
Place at admission: an agency staff was asked, ''Where was the sampled patient staying when (he or she) first began receiving hospice care?'' Response options were:
1. this agency's inpatient/residential facility; 2. private home or apartment; 3. residential care place; 4. skilled nursing facility (nursing home)hospital; 5. 91. other place (specify).
The wording of option 1 presents a problem with our study purposes. Although a hospice agency tends to transfer only those patients admitted to its own hospice program to its own HIRF, it is not rare for some agencies without their own facilities to transfer their patients to other agencies' HIRFs. For example, for several patients in our NHHCS data, agency staff specified ''contract hospice house'' as ''other place,'' option 91. We carefully examined all of the specified other place types. If the other place indicated an HIRF variant (eg, hospice house), it was recorded as option 1, instead of 91. For analytical purposes, categories 3, 4, and 91 (except for HIRF variants) were combined into the nursing home/other residential group category. There were only a small number of cases (8 records) with category 91, except for HIRF variants 3 records were mostly associated with residential care facilities (e.g., adult foster care) and 5 records were missing names.
Place at discharge: the NHHCS asked the question, ''Where was the sampled patient staying on the last day (he or she) received hospice care?'' The options were identical to those for the question concerning place at admission. We recoded 91 to 1 if the specified other place indicated an HIRF variant. For analytical purposes, categories 3, 4, and 91 (except for HIRF variants) were combined into the nursing home/other residential group. There were 30 cases with category 91 except for HIRF variants, 27 names were mostly associated with residential care facilities (eg, senior citizen housing) and 3 were missing names.
Emergency care: The NHHCS asked the question, ''Did the patient use any of these services for emergent care during the last 60 days (prior to interview) since admission?'' The staff's response options included: In our study, emergency care was dichotomized to emergent care and no emergent care (option 4).
Continuity of place of residence from first to last received hospice care: the Center for Disease Control and Prevention's (CDC) Center for Health Statistics derived this variable from the answers to the 2 questions regarding places at admission and at discharge. The variable had 2 values (the same or different).
Level of care at discharge: The NHHCS data report levels of care at discharge only. A hospice agency can bill at 1 of the 4 levels of care per day: routine home care, continuous home care, GIP care, and respite inpatient care. Routine home care, which is reimbursed at the lowest reimbursement rate, is the default level of care. The GIP care, which is reimbursed at the highest rate, should be provided only in places of service specified by Medicare-a Medicare-certified HIRF, an SNF, or an inpatient hospital. Respite level of care can be provided in a nursing home, in addition to the 3 places allowed for GIP care above. Continuous home care may be provided only in the places that patients consider as home. For our analysis, GIP care and respite care are combined into 1 category.
Statistical Approaches and Outcome Measures
The 2007 NHHCS patient file includes both home health patients and discharged hospice patients in 1 file. The NHHCS sponsor, the CDC, strongly recommends that home health patient records not be removed or deleted, even though a study may focus exclusively on hospice discharged patients. If home health patients were to be excluded from the study data, the analytical data would not have a full range of the 2 sampling design variables: 9 strata (3 agency types: home health, hospice, and mixed; and 3 agency locations: metro, micro, and neither) and all clusters (ie, home health and hospice agencies). This would lead to incorrect standard errors for significance testing. [19] [20] [21] Instead of removing home health patients, the CDC recommends the use of the technique called ''domain'' analysis (for SAS) 22 or a ''subpopulation'' analysis (for STATA). 23 Accordingly, for demographic/clinical characteristics of discharged hospice patients, we used PROC SURVEY-FREQ with survey design variables properly included in order to report weighted percentages with corresponding 95% confidence intervals (CI). The PROC SURVEYLOGISTIC with domain statement was used for the binomial logistic regression analyses to determine factors that affect HIRF and hospital hospice care use.
Use of HIRFs: using both places at admission and at discharge, we created a measure of HIRF utilization. If a patient used an HIRF either at admission or at discharge, the patient was recorded as having utilized an HIRF. There was no information available from NHHCS on the number of times the patient was transferred; therefore, the patient could have changed sites only once or multiple times. Binomial logistic regression was used to measure this dichotomous variable.
Use of hospital hospice care: similarly, using both places at admission and at discharge, we created a measure of hospital hospice care use. If a patient used care provided in a hospital either at admission or at discharge, the patient was recoded as having utilized a hospital. When we assessed the overlap of this variable with the use of an HIRF, little overlap was found. Binomial logistic regression was used to measure this hospital care use variable.
Patient Characteristics
Patient characteristics we examined include readmission to hospice, category of days hospice care received (in categories of less than 7 days, 7-30 days, 31-180 days, and 181 days or longer), reason for discharge (death or discharged alive), patient demographics (gender, age, marital status), primary payment source (eg, Medicare/Medicaid), whether having a primary caregiver, diagnoses classified into 3 groups using codes from the International Classification of Diseases, Ninth Revision, Clinical Modification (cancer [140-239], dementia [290.0, 290.42, 294.8, 294.9, 331.0, 331.11, 331.4, 331.82, and 331.9], and other), emergency care received, and metropolitan statistical area (MSA). The MSA is part of an agency characteristic, defined as whether the hospice agency is part of the MSA, categorized by the US Census as metropolitan (at least 1 urban area with a population 50 000), micropolitan (an area with a population of 10 000-49 999), or ''neither,'' (eg, rural). We used this MSA variable as a proxy measure for the location of patients' residences.
Results
Locations of Care of Hospice Patients
Our study was based on 4727 patients discharged from hospices in 2007, representative of an estimated 1.03 million patients discharged from hospices in 2007. Table 1 presents the locations of care of hospice patients prior to their hospice stay, at hospice admission, and at discharge after hospice enrollment. About 4 in 10 hospice patients were in the hospital before hospice enrollment. About 7% of the hospice patients at admission were placed in the HIRF, while 14% were discharged from the HIRF. About 10% started to receive hospice care in the hospital, while 9% were discharged from the hospital. For about 17% of the hospice patients, the location of care changed during their hospice stay. About 14% of the hospice patients were in the HIRF during all or part of their hospice stay, while 13% spent time in the hospital.
About 90% of the patients in HIRFs at discharge were receiving a GIP or respite level of care (with 10% receiving the routine level of care), compared to 77% of the patients in hospitals receiving GIP or respite levels of care (with 23% receiving routine home care). The 23% of hospice patients in the hospital who were receiving routine home care at discharge may have been receiving treatment for a condition completely unrelated to the terminal condition. In such cases, Medicare paid the hospice agency at the rate of routine home care for continuing case management services, including coordination of care and discharge planning, while the hospital filed a claim for treatment with regular Medicare hospital benefits.
Other Characteristics of Hospice Patients
The demographic and hospice use variables are presented in Table 2 . About 17% of the hospice patients were 0 to 64 years old, with 38% being 85 and older. About 9% had no caregiver; about 7% had unplanned emergent care; and about 84% died at discharge. About 32% were discharged within less than 1 week. About 4% of hospices were located in rural areas (neither metropolitan nor micropolitan areas). Table 3 presents odds ratios and CIs from a logistic regression of HIRF use as a binary variable. Patients with a caregiver were less likely to use HIRFs. Patients with dementia were also less likely to use HIRFs. In contrast, 5 characteristics of the patients were positively associated with HIRF use and they include (1) being in the hospital before hospice enrollment; (2) being placed in the different places at admission and at discharge; (3) being discharged within less than 1 week; (4) death discharge; and (5) being enrolled in hospice agencies located in metropolitan areas.
Characteristics Associated With Hospice Inpatient/ Residential Facility Use
Characteristics Associated With Hospital Hospice Use
The characteristics associated with hospital care use were very similar to those associated with HIRF use (Table 4 ). However, there were 3 exceptions (1) there was no statistically significant relationship between patients dying at discharge and hospital care use during their hospice stay; (2) whether patients had unplanned emergent care was strongly related to hospital care use; and (3) patients whose hospice agencies were located in rural areas were more likely to use care provided in hospitals during their hospice stay.
Discussion
Using a national representative sample of patients discharged from hospices in 2007, we found that about 1 in 5 hospice patients received hospice care provided in either HIRFs or hospitals during their hospice stay. In addition, about 17% of the hospice patients changed their location of care during their hospice stay; some of them were transferred from their home to an HIRF or hospital. This is contrary to the popular belief that hospice patients often stay in the same place until death. Our findings suggest that in 2007, hospice agencies utilized HIRFs for patients with no primary caregiver outside of the agency and for patients who came close to death, the two patient characteristics that were not significantly associated with hospital use. We also found that the level of care for the majority of HIRF patients (90% of HIRF patients) in 2007 was the GIP level of care-the highest reimbursement rate per day that agencies can receive for a patient. However, concerns that this GIP level of care was being misused, along with the rapid growth of Medicare hospice spending, prompted a large scale of audits on GIP claims in 2008, with over 40% of 770 GIP claims reviewed being denied, amounting to more than 1.5 million dollars denied. 24 The Office of the Inspector General (OIG) continued to list a medical review of GIP care in its Work Plan, for the FY 2011, 2012, and 2013 consecutively. [25] [26] [27] The OIG 2012 Work Plan included a project that assessed the appropriateness of hospices' GIP care claims made between 2005 and 2010. 26 It also included a plan of targeting claims for GIP care for patients directly admitted from a hospital to a hospice and examining the relationships-financial and/or ownership arrangements-between the hospital and the hospice. The OIG's 2013 Work Plan also has a review of GIP care in 2011. 27 Articles from audit results are available to hospice providers. After a medical review of 34 GIP paid claims by 7 Rhode Island Medicaid hospice programs, the OIG reported in 2012 that 19 of the 34 claims did not meet the requirements for GIP care and should have been billed as routine home care. 28 Another review focused on GIP care claims highly vulnerable to fraud; one such type was GIP care of 7 or more days in a monthly billing period; this edit reported a denial rate of nearly 62%. 29 Armed with these audit results, the Centers for Medicare and Medicaid Services (CMS) has made it clear to hospice providers that care can be billed at the GIP level in the event of imminent death, a direct discharge from a hospital to a hospice, or a caregiver breakdown, but only when the hospice provider can provide the documentation supporting a need for aggressive pain/symptom management. 30 Hospice care billed previously as GIP care is now strictly reimbursed only at the routine care rate or respite care rate, leading to a considerable reduction in payments. This stricter enforcement may have dampened agencies' frenzied pace in building new freestanding HIRFs and/or may have induced some agencies to close their existing HIRFs. Indeed, 1 agency in Michigan recently closed its 2 HIRFs, citing the reduction in reimbursement rate from the GIP level to routine level of care. 31 Since room and board cost is not reimbursed when an HIRF patient receives the routine level of care, agencies would try to avoid opening a new HIRF in communities where the residents cannot afford the expensive room and board cost. A future study, evaluating state policies of financial support for room and board costs of Medicaideligible HIRF residents, is needed to assess the potential impact of such financial support on the availability of HIRFs. There was another noteworthy finding, patients served by hospice agencies located in rural areas were more likely than those served by agencies in metropolitan areas to use care provided in hospitals. This suggests that, despite a relatively equitable geographic distribution of in-home hospice programs, 32 the HIRF beds may not be available to patients in rural areas. In other areas, swing beds are one option for hospice care; they are more likely to be the only option in the most rural areas for patients in crisis due to symptoms related to their hospice diseases. If those patients had lived in metropolitan areas where HIRF beds were available, they may have been transferred to an HIRF, not to a hospital. Given that patients in rural areas tend to live alone or have no capable caregiver in their homes, and a hospice agency reported very high traveling costs to deliver care to rural areas, the CMS funded a ''rural hospice'' demonstration project in 2005 where 2 HIRFs were selected to provide both residential and inpatient hospice care services. 33 There was no specific payment method for room and board, except that the awardees did not have to comply with the 20% cap on inpatient care days for these individuals. One of the two selected hospices placed all project-participating patients in its newly constructed inpatient facility, which became the first of its kind in the demonstration area. During the evaluation period of calendar year 2007, GIP care accounted for slightly over 4% of hospice days in the hospice, compared to 0.9% among the demonstration community except the hospice. 34 This was due to a large difference in the number of patients who received GIP care during the hospice stay. Prior to the demonstration, 3% of the hospice decedents in the demonstration community received GIP care, compared to 19%. And the hospice facility accounted for 63% of the decedents in the demonstration community who received GIP care. 34 The secretary of DHHS concluded that findings based on only 1 hospice are not generalizable and recommended that this business model not be expanded to other rural hospices. 34 Although some states use HIRF licensure laws or Certificate of Need (CON) programs to ensure an equitable distribution of HIRF beds across geographic areas, there is currently no systematic review of state policies relevant to the distribution of HIRF beds.
We have to note some limitations. First of all, the reported rates of HIRF and hospital hospice use may be underestimated. The NHHCS data record the patients' locations on the first and last days of hospice care but do not record how many times they were transferred to other sites in between the first and last days of hospice care. Furthermore, the NHHCS excludes HIRFs operated by other agencies than the surveyselected agencies. Although we attempted to identify HIRFs that would otherwise have been classified as ''other'' sites, not all ''other'' sites were specified by the staff.
Conclusion
About 14% of the patients discharged from hospices in 2007 received care in an HIRF during all or part of their hospice stay, while a very similar percentage (13%) of patients received care provided in a hospital. The characteristics of patients associated with HIRF use largely match the characteristics of patients receiving a GIP level of care, according to CMS billing reimbursement data, and include having no caregiver or having an incapable caregiver due to stress or illness; having imminent death; and being directly admitted to a hospice after discharge from a hospital. The recently stepped-up scrutiny of GIP level of care may have chilly effects on hospice agencies' attempts to increasing HIRF beds. We call for close monitoring of any resulting shifts in the availability of HIRF beds, particularly in rural and low-income urban areas, where the availability of HIRF beds can be chillingly disproportionate.
